Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • How smart spaces and real-time strategy transformed ASCO® 2025

    August 19, 2025 | Congress, Inizio, oncology 

    - PMLiVE

    Nick Bellomo, Director of Technology and Engagement, Inizio Medical

    ASCO® 2025 wasn’t just about oncology breakthroughs – it was also a showcase for how technology is redefining congress engagement. Supporting dozens of clients with hundreds of deliverables, Inizio had a front-row seat to innovations that are reshaping how healthcare professionals (HCPs) learn and interact.

    Highlights from the floor:

    • LED walls reimagined: Once static displays, LED walls are now interactive storytelling tools. From gesture-responsive MOAs to live trial dashboards, these experiences empowered HCPs to navigate content at their own pace, boosting engagement and driving more meaningful conversations.

    • Real-time in-booth analytics: Inizio piloted offline analytics that delivered live insights without internet dependency. This allowed brands to refine content mid-show, optimize staff alignment, and deliver more targeted education – all during the congress, not weeks later.

    Why it matters:
    These shifts mark a broader transformation: moving from passive storytelling to responsive engagement, and from delayed insights to real-time adaptability. For HCPs, this means richer, more relevant learning. For brands, it means smarter strategies and more impactful outcomes.

    At Inizio, the booth is no longer just a backdrop – it’s a catalyst for strategic engagement and patient-focused progress.

    Read the full article authored by Nick here. Discover more in the on-demand webinar Beyond the booth: Big ideas, smart spaces & strategic insights from ASCO® 2025.

    This content was provided by Inizio

    Company Details

    - PMLiVE

    Inizio

    Email
    Website

     Latest Content from  Inizio 

    Delivering purposeful solutions at Obesity Week 2025

    We’re attending Obesity Week 2025, the world’s leading event dedicated to obesity research and care, to showcase how our integrated expertise is advancing progress in obesity and cardiometabolic health.

    Inizio strengthens executive team with new leadership appointments

    Inizio has appointed Mary-Kate McGarry as Chief Strategy & Innovation Officer and Gavin McShera as Chief Information Officer, strengthening its executive leadership to drive innovation, digital transformation, and Intelligent Commercialization™...

    Inizio celebrates six finalist honors at the 2025 PM360 Trailblazer Awards

    Inizio has been named a finalist in six categories at the 2025 PM360 Trailblazer Awards, recognizing its teams’ excellence in AI, data analytics, education, patient engagement, and industry partnership across...

    Inizio leaders featured in Forbes’ ‘Voices of Oncology’ to drive innovation in cancer care

    Inizio experts contribute to Forbes’ Voices of Oncology, highlighting our commitment to driving innovation in cancer care through advanced data analytics, cross-sector collaboration, and real-world impact for patients.

    Inizio appoints Ryan Quigley as CEO

    Inizio have appointed Ryan Quigley as Chief Executive Officer, effective 9 September 2025. Paul Taaffe will remain closely involved with the company as an Advisor and board member going forward. ...

    What oncologists really want from booth strategy

    Simon Davenport, Global Head of Environments, Emota, an Inizio Engage company  At this year’s ASCO® congress, the spotlight wasn’t just on science – it was on how the industry engages. Supporting over 30...

    How smart spaces and real-time strategy transformed ASCO® 2025

    Nick Bellomo, Director of Technology and Engagement, Inizio Medical ASCO® 2025 wasn’t just about oncology breakthroughs - it was also a showcase for how technology is redefining congress engagement. Supporting...

    The science is shifting in oncology: Are you ready to evolve with it?

    Patty Zipfel, PhD, SVP, Scientific Strategy, Inizio Evoke. This year’s ASCO® meeting spotlighted a bold shift in oncology: the possibility of curing metastatic disease. A new trial design in metastatic...

    Reimagine health with Inizio.

    At Inizio, we provide tailored, innovative solutions to help health and life sciences companies with their clinical development and commercialization journeys, maximizing patient access. Our experts guide you through each...

    Kathy O’Connell joins Research Partnership as Senior Vice President, Business Development

    Kathy has been working in the pharmaceutical market research industry for over 25 years. She has a diverse business background, with in-depth experience in progressively responsible sales, business development and...